CLCN7 and hypopigmentation, organomegaly, and delayed myelination and development: In all patients known to date, HOD-causing mutations are present in a heterozygous state, in which mutant/mutant ClC-7 dimers are predicted to constitute only one-fourth of the total number of transporters.